Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation

Overview of attention for article published in Lancet Oncology, January 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news: 1 news outlet
twitter: 11 X users
patent: 3 patents

facebook: 1 Facebook page
guideline: 3 clinical guideline sources

Readers on

mendeley: 241 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 11 X posts from 11 X users, with an upper bound of 78,191 followers.

Great original work by @PayalKapur5 https://t.co/0qF7Hnv4xy

RT @arihakimi: For some context, we know that specific mutations are associated with worse outcomes, in ccRCC. See work from @JBrugarolas e…

For some context, we know that specific mutations are associated with worse outcomes, in ccRCC. See work from @JBrugarolas et al https://t.co/uzRP7oB4R5 and our group https://t.co/ng9JZutMza

RT @Sam_PenaLlopis: @DanaFarberNews @OncoAlert @JAMAOnc @DrChoueiri @VanAllenLab This also validates beautifully the use of our classificat…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 7 additional X posts.